In brief: Pfizer allegedly to invest €1bn in Irish manufacturing

Pfizer has refused to comment on claims made by the Irish press it is investing €1 billion in its Grange Castle biomanufacturing site.

Dan Stanton, Editorial director

October 24, 2022

1 Min Read
In brief: Pfizer allegedly to invest €1bn in Irish manufacturing
Image: DepositPhotos/ ventanamedia

Pfizer has refused to comment on claims made by the Irish press it is investing €1 billion ($1 billion) in its Grange Castle biomanufacturing site.

The 90-acre manufacturing site in Clondalkin in Dublin was opened in 2006 following a $2 billion investment by Wyeth (which Pfizer acquired in 2009). The site has benefitted from continual investments and expansion since, including a $40 million mRNA expansion to support the firm’s COVID-19 vaccine efforts.

But now Pfizer could be ready to invest €1 billion into the site, according to the Business Post. The outlet reported Saturday that construction of a new biomanufacturing facility will begin next summer, with completion set for the end of 2026.

Depositphotos_65862189_S-300x200.jpg

Image: DepositPhotos/
ventanamedia

However, when contacted by BioProcess Insider, Pfizer refused to comment on the proposed investment:

“We do not comment on speculation,” a spokesperson said. “Pfizer is constantly assessing our manufacturing network to ensure we can continue to bring our breakthroughs to patients.”

About the Author

Dan Stanton

Editorial director

Journalist covering the international biopharmaceutical manufacturing and processing industries.
Founder and editor of Bioprocess Insider, a daily news offshoot of publication Bioprocess International, with expertise in the pharmaceutical and healthcare sectors, in particular, the following niches: CROs, CDMOs, M&A, IPOs, biotech, bioprocessing methods and equipment, drug delivery, regulatory affairs and business development.

From London, UK originally but currently based in Montpellier, France through a round-a-bout adventure that has seen me live and work in Leeds (UK), London, New Zealand, and China.

You May Also Like